Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ginkgo Bioworks Holdings, Inc. (DNA)

2.66   0.28 (11.76%) 05-16 07:57
Open: 2.51 Pre. Close: 2.38
High: 2.76 Low: 2.45
Volume: 33,743,217 Market Cap: 4,721(M)
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.76 - 2.78 2.78 - 2.79
Low: 2.42 - 2.43 2.43 - 2.45
Close: 2.63 - 2.66 2.66 - 2.68

Technical analysis

as of: 2022-05-16 7:47:30 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.81     One year: 4.65
Support: Support1: 2.09    Support2: 1.74
Resistance: Resistance1: 3.26    Resistance2: 3.98
Pivot: 2.87
Moving Average: MA(5): 2.46     MA(20): 3.06
MA(100): 4.7     MA(250): 8.45
MACD: MACD(12,26): -0.4     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 26     %D(3): 17.2
RSI: RSI(14): 41.5
52-week: High: 15.86  Low: 2.09
Average Vol(K): 3-Month: 20,601 (K)  10-Days: 26,027 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DNA ] has closed above bottom band by 37.3%. Bollinger Bands are 30.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 16 May 2022
Exploring phylogenetic relationships within the subgenera of Bambusa based on DNA barcodes and morphological characteristics | Scientific Reports -

Mon, 16 May 2022
New York DNA measure touted as key to justice for violent cold cases - Bluefield Daily Telegraph

Mon, 16 May 2022
Sex offenders required forced into compliance with DNA requirement - Columbia Basin Herald

Mon, 16 May 2022
DNA Sequencing in Drug Discovery Market: increasing adoption of novel sequencing technologies to drive the market - BioSpace

Mon, 16 May 2022
Rangers' refusal to surrender mirrors 2015 team's winning DNA - New York Post

Sun, 15 May 2022
DNA Testing Identifies Remains Found In Colorado In 1994 As Susan Hoppes - CBS Denver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 1,190 (M)
Shares Float 318 (M)
% Held by Insiders 7.5 (%)
% Held by Institutions 73.4 (%)
Shares Short 42,910 (K)
Shares Short P.Month 18,720 (K)

Stock Financials

EPS -8.7
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.03
Profit Margin (%) -140
Operating Margin (%) -100.9
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 483.3
Gross Profit (p.s.) 0.05
Sales Per Share 0.16
EBITDA (p.s.) -0.15
Qtrly Earnings Growth 0
Operating Cash Flow -148 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.31
PEG Ratio 0
Price to Book value 2.55
Price to Sales 16.03
Price to Cash Flow -21.45

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.